Soufien Bennamou

Folate and Homocysteine in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease or Dementia: A Case Control Study

Mohamed Ali Smach, Nelly Jacob, Jean‐Louis Golmard et al. · European Neurology · 2011 · 52 citations

Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer’s Disease

Mohamed Ali Smach, Hayet Edziri, Bassem Charfeddine et al. · Dementia and Geriatric Cognitive Disorders Extra · 2012 · 37 citations · Full text

Evaluation of Cerebrospinal Fluid Tau/Beta-Amyloid(42) Ratio as Diagnostic Markers for Alzheimer Disease

Mohamed Ali Smach, Bassem Charfeddine, Leila Ben Othman et al. · European Neurology · 2009 · 28 citations

CSF β-amyloid 1–42 and tau in Tunisian patients with Alzheimer's disease: The effect of APOE ɛ4 allele

Mohamed Ali Smach, Bassem Charfeddine, Turkia Lammouchi et al. · Neuroscience Letters · 2008 · 22 citations

Neurodegenerative Diseases, Alzheimer's Disease, Apoe ɛ4 Allele +10

−1154G/A and −2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to β-amyloid (1–42) and total tau protein

Mohamed Ali Smach, Bassem Charfeddine, Leila Ben Othman et al. · Neuroscience Letters · 2010 · 13 citations

Neurodegenerative Diseases, Total Tau Protein, Alzheimer's Disease +10